Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure

Phase 3 Completed 85 enrolled Taiwan Otsuka Pharm. Co., Ltd

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A Multicenter, Double-blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients with Heart Failure

Timeline

Start: 2012-07
Primary completion: 2014-05
Completion: 2014-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tolvaptan	Small molecule	15 mg	—

Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure

Summary

Timeline

Drugs

Indications